期刊
JOURNAL OF HEPATOLOGY
卷 75, 期 5, 页码 1203-1216出版社
ELSEVIER
DOI: 10.1016/j.jhep.2021.07.027
关键词
liver transplantation; donor-specific antibody; histology; HLA; antibody-mediated rejection
Antibody-mediated rejection after liver transplantation is a lesser recognized cause of allograft injury, with challenges in timely diagnosis and treatment, highlighting the need for further research and development in this area.
Antibody-mediated rejection after liver transplantation is an under-recognised cause of allograft injury. While definitions of acute and chronic antibody-mediated rejection have increased clinical awareness, timely identification and management of antibody-mediated rejection remain difficult because of complexities in diagnosis and histopathology, lack of treatment protocols, and unclear long-term outcomes. While recent cohort studies assessing the importance of donor-specific antibodies have aided in its diagnosis, literature on the treatment of antibody-mediated rejection in liver transplantation remain limited to case reports and small series. Further increasing the awareness and timely recognition of antibody-mediated rejection post-liver transplantation is crucial in order to stimulate future research and the development of protocols for its diagnosis and treatment. This review will summarise recent advances in the clinical diagnosis and treatment of antibody-mediated rejection in liver transplantation, as well as some of the histopathologic features (on liver biopsy tissue) of acute and chronic antibody-mediated rejection. (C) 2021 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据